The FDA’s Updated Approach to Wellness Tech: A Closer Look
The U.S. Food and Drug Administration (FDA) released its 2026 guidance on Low-Risk General Wellness Devices on January 6, replacing the 2019 version and bringing much-needed clarity to how wellness technologies should be designed and marketed in today’s digital health ecosystem. The document is short, but its implications stretch across fitness bands, smartwatches, health apps, […]
UAE Health-tech Platforms: How to Ensure Ongoing Compliance
Summary Upon incorporation of a HealthTech platform in the UAE, ongoing legal, regulatory and technical obligations begin immediately. HealthTech is one of the UAE’s most tightly supervised sectors, with regulators such as the Dubai Health Authority (DHA), Ministry of Health and Prevention (MOHAP) and Emirates Drug Establishment (EDE) requiring consistent compliance. Post-incorporation compliance is not […]
Federal Decree-Law No. 6 of 2025: All you need to know about the UAE’s New Banking and Insurance Law
Summary On 8 September 2025, the UAE issued Federal Decree-Law No. 6 of 2025 Regarding the Central Bank, the Regulation of Financial Institutions, their Activities, and Insurance Business (the Law). Effective 16 September 2025, the Law replaces previous frameworks and consolidates supervision under the Central Bank of the UAE (CBUAE). With a one-year transition period […]
Netflix And Paramount Battle for Warner: Part 3
When Netflix and Paramount each made their offers for Warner Bros. Discovery (WBD), they did not simply bid different prices and hope for the best. Each side constructed their own complex, multi-layered transaction embedded with termination rights, regulatory safeguards, and risk allocation mechanisms that, in many ways, matter as much as the headline dollars do. […]
Netflix And Paramount Battle for Warner: Part 2
As we covered in Part 1 of this series, Netflix announced a definitive agreement to acquire Warner Bros. Studios, HBO, HBO Max, DC Entertainment, and TNT Sports for $27.75 per share on 5 December, valuing the deal at approximately $72 billion. Three days later, Paramount launched a hostile, all-cash bid directly to shareholders at $30 […]
The EU Digital Omnibus on AI: All You Need to Know About The Proposed Amendments to the EU AI Act
Summary On 19 November 2025, the European Commission (the “Commission”) published its Digital Omnibus on AI, a legislative proposal to streamline implementation of the EU Artificial Intelligence Act (the “Act”). The proposal addresses delays in harmonized standards and guidance while adjusting compliance timelines and reducing administrative burdens. Key points: High-risk AI system compliance deadlines extended, […]
Netflix And Paramount Battle for Warner: Part 1
In this series of articles, we examine the competing proposals by Netflix and Paramount for the acquisition of Warner Bros. Discovery, unpacking not only the financial and strategic dimensions but also the antitrust and regulatory issues that will ultimately influence the fate of these deals. Overview In September 2025, Warner Bros. Discovery found itself at […]
Getty Images v Stability AI: Another Legal Win for AI Against Copyright Holders
On 4 November 2025, the High Court in London delivered judgment in Getty Images (US) Inc & Ors v Stability AI Ltd. Summary The dispute centred on Getty Images’ claims that Stability AI’s generative model, Stable Diffusion, had unlawfully used its copyrighted material and trade marks. The judgment delivered mixed outcomes: Getty secured limited trade […]
Reddit vs. Perplexity: A Closer Look
On Oct. 22, 2025 Reddit filed a lawsuit in the Southern District of New York accusing the defendants Perplexity AI and three scraping intermediaries – Oxylabs UAB, AWMProxy and SerpApi (“intermediaries”) of participating in an “industrial-scale” operation to harvest Reddit comments and use them for commercial purposes. The complaint seeks damages and an injunction to […]
The UK Streamlines Market Entry for Medical Devices: A Closer Look
In May last year, the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) published a policy statement regarding international recognition of regulatory approvals of medical devices. In July this year, MHRA announced it had reviewed feedback from stakeholders on its proposed policy from May and that it has decided to move forward with its proposal. […]
